查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
血液篩檢市場：按產品、技術和最終用戶分類：2023-2032 年全球機會分析和產業預測
市場調查報告書
商品編碼
1414733

血液篩檢市場：按產品、技術和最終用戶分類：2023-2032 年全球機會分析和產業預測

Blood Screening Market By Product (Instruments, Kits and Reagents), By Technology (NAT Technology, Immunoassays), By End User (Blood Banks, Hospitals): Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 240 Pages | 商品交期: 2-3個工作天內

價格

2022 年血液篩檢市場價值為 24 億美元，預計 2023 年至 2032 年複合年成長率為 7.5%，到 2032 年將達到 49 億美元。

2022年至2032年，血液篩檢市場可能會出現7.5%的顯著成長率。這是由於各種醫療應用對捐血的需求不斷增加以及全球捐血數量的迅速增加。

血液篩檢市場-IMG1

目錄

第1章簡介

第 2 章執行摘要

第3章市場概況

  • 市場定義和範圍
  • 主要發現
    • 影響因素
    • 主要投資機會
  • 波特五力分析
  • 市場動態
    • 促進因素
      • 醫療捐血需求增加
      • 全球捐血快速增加
    • 抑制因素
      • 監管障礙
    • 機會
      • 提高對透過輸血傳染疾病的認知

第4章血液篩檢市場，分產品

  • 概述
  • 裝置
  • 套件和試劑

第5章血液篩檢市場：依技術分類

  • 概述
  • 網路位址轉換技術
    • 按 NAT 技術分類的血液篩檢市場：按類型
  • 免疫檢測
    • 按類型分類的免疫檢測分析血液篩檢市場

第6章血液篩檢市場：依最終用戶分類

  • 概述
  • 血庫
  • 醫院

第7章血液篩檢市場：依地區

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 其他
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 其他
  • 拉丁美洲/中東/非洲
    • 巴西
    • 南阿拉伯
    • 南非
    • 其他

第8章 競爭形勢

  • 介紹
  • 關鍵成功策略
  • 10家主要企業產品圖譜
  • 競爭對手儀表板
  • 競爭熱圖
  • 2022年主要企業定位

第9章 公司簡介

  • F. Hoffmann-La Roche Ltd.
  • Grifols, SA
  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • Siemens AG
  • Avioq, Inc.
  • Alive DX
  • QuidelOrtho Corporation.
Product Code: A02491

According to a new report published by Allied Market Research, titled, "Blood Screening Market," The blood screening market was valued at $2.4 billion in 2022, and is estimated to reach $4.9 billion by 2032, growing at a CAGR of 7.5% from 2023 to 2032. The Blood Screening Market is likely to experience a significant growth rate of 7.5% from 2022-2032, owing to rise in demand of donated blood for various medical applications and surge in number of blood donations globally.

Blood Screening Market - IMG1

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blood screening market analysis from 2022 to 2032 to identify the prevailing blood screening market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the blood screening market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global blood screening market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product

  • Instruments
  • Kits and Reagents

By End User

  • Blood Banks
  • Hospitals

By Technology

  • NAT Technology
    • Type
    • Transcription Mediated Amplification (TMA)
    • Real time PCR
    • NGS
  • Immunoassays
    • Type
    • Enzyme immunoassays (EIAs)
    • Chemiluminescent immunoassays (CLIAs)
    • Particle agglutination (PA) assays
    • Rapid assays
    • Western Bloat
    • ELSA

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • South Arabia
    • South Africa
    • Rest of LAMEA

Key Market Players:

    • Grifols, S.A.
    • Abbott Laboratories
    • Danaher Corporation
    • DiaSorin S.p.A.
    • Avioq, Inc.
    • F. Hoffmann-La Roche Ltd.
    • Bio-Rad Laboratories, Inc.
    • Siemens AG
    • Alive DX
    • QuidelOrtho Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in demand for donated blood for medical applications.
      • 3.4.1.2. Surge in number of blood donations globally.
    • 3.4.2. Restraints
      • 3.4.2.1. Regulatory Hurdles.
    • 3.4.3. Opportunities
      • 3.4.3.1. Rise in awareness about diseases transmitted through transfusion.

CHAPTER 4: BLOOD SCREENING MARKET, BY PRODUCT

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Instruments
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Kits and Reagents
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: BLOOD SCREENING MARKET, BY TECHNOLOGY

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. NAT Technology
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
    • 5.2.4. NAT Technology Blood Screening Market by Type
  • 5.3. Immunoassays
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Immunoassays Blood Screening Market by Type

CHAPTER 6: BLOOD SCREENING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Blood Banks
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Hospitals
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: BLOOD SCREENING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product
    • 7.2.3. Market size and forecast, by Technology
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product
      • 7.2.5.1.2. Market size and forecast, by Technology
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product
      • 7.2.5.2.2. Market size and forecast, by Technology
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product
      • 7.2.5.3.2. Market size and forecast, by Technology
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product
    • 7.3.3. Market size and forecast, by Technology
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product
      • 7.3.5.1.2. Market size and forecast, by Technology
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product
      • 7.3.5.2.2. Market size and forecast, by Technology
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product
      • 7.3.5.3.2. Market size and forecast, by Technology
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product
      • 7.3.5.4.2. Market size and forecast, by Technology
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product
      • 7.3.5.5.2. Market size and forecast, by Technology
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product
      • 7.3.5.6.2. Market size and forecast, by Technology
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product
    • 7.4.3. Market size and forecast, by Technology
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. China
      • 7.4.5.1.1. Market size and forecast, by Product
      • 7.4.5.1.2. Market size and forecast, by Technology
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. Japan
      • 7.4.5.2.1. Market size and forecast, by Product
      • 7.4.5.2.2. Market size and forecast, by Technology
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product
      • 7.4.5.3.2. Market size and forecast, by Technology
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product
      • 7.4.5.4.2. Market size and forecast, by Technology
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product
      • 7.4.5.5.2. Market size and forecast, by Technology
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product
      • 7.4.5.6.2. Market size and forecast, by Technology
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. LAMEA
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product
    • 7.5.3. Market size and forecast, by Technology
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product
      • 7.5.5.1.2. Market size and forecast, by Technology
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. South Arabia
      • 7.5.5.2.1. Market size and forecast, by Product
      • 7.5.5.2.2. Market size and forecast, by Technology
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. South Africa
      • 7.5.5.3.1. Market size and forecast, by Product
      • 7.5.5.3.2. Market size and forecast, by Technology
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest of LAMEA
      • 7.5.5.4.1. Market size and forecast, by Product
      • 7.5.5.4.2. Market size and forecast, by Technology
      • 7.5.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. F. Hoffmann-La Roche Ltd.
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
  • 9.2. Grifols, S.A.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Abbott Laboratories
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
  • 9.4. Bio-Rad Laboratories, Inc.
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. Danaher Corporation
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
  • 9.6. DiaSorin S.p.A.
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. Siemens AG
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
  • 9.8. Avioq, Inc.
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
  • 9.9. Alive DX
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
  • 9.10. QuidelOrtho Corporation.
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance

LIST OF TABLES

  • TABLE 01. GLOBAL BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 02. BLOOD SCREENING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. BLOOD SCREENING MARKET FOR KITS AND REAGENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. GLOBAL BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 05. BLOOD SCREENING MARKET FOR NAT TECHNOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 06. GLOBAL NAT TECHNOLOGY BLOOD SCREENING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 07. BLOOD SCREENING MARKET FOR IMMUNOASSAYS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. GLOBAL IMMUNOASSAYS BLOOD SCREENING MARKET, BY TYPE, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. BLOOD SCREENING MARKET FOR BLOOD BANKS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. BLOOD SCREENING MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. BLOOD SCREENING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. NORTH AMERICA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA BLOOD SCREENING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 17. U.S. BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. U.S. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 19. U.S. BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. CANADA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. CANADA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 22. CANADA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. MEXICO BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. EUROPE BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 30. GERMANY BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. UK BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. UK BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 38. UK BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 41. ITALY BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC BLOOD SCREENING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 52. CHINA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 53. CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 54. CHINA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 57. JAPAN BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. INDIA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 60. INDIA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. LAMEA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. LAMEA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 72. LAMEA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. LAMEA BLOOD SCREENING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 74. BRAZIL BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 77. SOUTH ARABIA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 78. SOUTH ARABIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 79. SOUTH ARABIA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 80. SOUTH AFRICA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 81. SOUTH AFRICA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 82. SOUTH AFRICA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 83. REST OF LAMEA BLOOD SCREENING MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LAMEA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LAMEA BLOOD SCREENING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 86. F. HOFFMANN-LA ROCHE LTD.: KEY EXECUTIVES
  • TABLE 87. F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT
  • TABLE 88. F. HOFFMANN-LA ROCHE LTD.: PRODUCT SEGMENTS
  • TABLE 89. F. HOFFMANN-LA ROCHE LTD.: PRODUCT PORTFOLIO
  • TABLE 90. GRIFOLS, S.A.: KEY EXECUTIVES
  • TABLE 91. GRIFOLS, S.A.: COMPANY SNAPSHOT
  • TABLE 92. GRIFOLS, S.A.: PRODUCT SEGMENTS
  • TABLE 93. GRIFOLS, S.A.: PRODUCT PORTFOLIO
  • TABLE 94. GRIFOLS, S.A.: KEY STRATERGIES
  • TABLE 95. ABBOTT LABORATORIES: KEY EXECUTIVES
  • TABLE 96. ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 97. ABBOTT LABORATORIES: PRODUCT SEGMENTS
  • TABLE 98. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 99. BIO-RAD LABORATORIES, INC. : KEY EXECUTIVES
  • TABLE 100. BIO-RAD LABORATORIES, INC. : COMPANY SNAPSHOT
  • TABLE 101. BIO-RAD LABORATORIES, INC. : PRODUCT SEGMENTS
  • TABLE 102. BIO-RAD LABORATORIES, INC. : PRODUCT PORTFOLIO
  • TABLE 103. BIO-RAD LABORATORIES, INC. : KEY STRATERGIES
  • TABLE 104. DANAHER CORPORATION: KEY EXECUTIVES
  • TABLE 105. DANAHER CORPORATION: COMPANY SNAPSHOT
  • TABLE 106. DANAHER CORPORATION: PRODUCT SEGMENTS
  • TABLE 107. DANAHER CORPORATION: PRODUCT PORTFOLIO
  • TABLE 108. DIASORIN S.P.A.: KEY EXECUTIVES
  • TABLE 109. DIASORIN S.P.A.: COMPANY SNAPSHOT
  • TABLE 110. DIASORIN S.P.A.: PRODUCT SEGMENTS
  • TABLE 111. DIASORIN S.P.A.: PRODUCT PORTFOLIO
  • TABLE 112. DIASORIN S.P.A.: KEY STRATERGIES
  • TABLE 113. SIEMENS AG: KEY EXECUTIVES
  • TABLE 114. SIEMENS AG: COMPANY SNAPSHOT
  • TABLE 115. SIEMENS AG: PRODUCT SEGMENTS
  • TABLE 116. SIEMENS AG: PRODUCT PORTFOLIO
  • TABLE 117. AVIOQ, INC.: KEY EXECUTIVES
  • TABLE 118. AVIOQ, INC.: COMPANY SNAPSHOT
  • TABLE 119. AVIOQ, INC.: PRODUCT SEGMENTS
  • TABLE 120. AVIOQ, INC.: SERVICE SEGMENTS
  • TABLE 121. AVIOQ, INC.: PRODUCT PORTFOLIO
  • TABLE 122. ALIVE DX: KEY EXECUTIVES
  • TABLE 123. ALIVE DX: COMPANY SNAPSHOT
  • TABLE 124. ALIVE DX: PRODUCT SEGMENTS
  • TABLE 125. ALIVE DX: PRODUCT PORTFOLIO
  • TABLE 126. QUIDELORTHO CORPORATION.: KEY EXECUTIVES
  • TABLE 127. QUIDELORTHO CORPORATION.: COMPANY SNAPSHOT
  • TABLE 128. QUIDELORTHO CORPORATION.: PRODUCT SEGMENTS
  • TABLE 129. QUIDELORTHO CORPORATION.: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01. BLOOD SCREENING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF BLOOD SCREENING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN BLOOD SCREENING MARKET (2022 TO 2032)
  • FIGURE 04. TOP INVESTMENT POCKETS IN BLOOD SCREENING MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL BLOOD SCREENING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. BLOOD SCREENING MARKET, BY PRODUCT, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR KITS AND REAGENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2022 AND 2032(%)
  • FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR NAT TECHNOLOGY, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR IMMUNOASSAYS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. BLOOD SCREENING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR BLOOD BANKS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BLOOD SCREENING MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 20. BLOOD SCREENING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 21. U.S. BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 22. CANADA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 23. MEXICO BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 24. GERMANY BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. FRANCE BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. UK BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. ITALY BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. SPAIN BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. REST OF EUROPE BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. CHINA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. JAPAN BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. INDIA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. AUSTRALIA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. SOUTH KOREA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. BRAZIL BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH ARABIA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. SOUTH AFRICA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. REST OF LAMEA BLOOD SCREENING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. TOP WINNING STRATEGIES, BY YEAR (2020-2023)
  • FIGURE 41. TOP WINNING STRATEGIES, BY DEVELOPMENT (2020-2023)
  • FIGURE 42. TOP WINNING STRATEGIES, BY COMPANY (2020-2023)
  • FIGURE 43. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 44. COMPETITIVE DASHBOARD
  • FIGURE 45. COMPETITIVE HEATMAP: BLOOD SCREENING MARKET
  • FIGURE 46. TOP PLAYER POSITIONING, 2022
  • FIGURE 47. F. HOFFMANN-LA ROCHE LTD.: SALES REVENUE, 2020-2022 ($MILLION)
  • FIGURE 48. F. HOFFMANN-LA ROCHE LTD.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 49. GRIFOLS, S.A.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 50. GRIFOLS, S.A.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 51. GRIFOLS, S.A.: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 52. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 53. ABBOTT LABORATORIES: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 54. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 55. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 56. BIO-RAD LABORATORIES, INC. : NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 58. BIO-RAD LABORATORIES, INC. : REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 59. DANAHER CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. DANAHER CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 61. DANAHER CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 62. DIASORIN S.P.A.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 63. DIASORIN S.P.A.: REVENUE SHARE BY REGION, 2021 (%)
  • FIGURE 64. SIEMENS AG: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 65. SIEMENS AG: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
  • FIGURE 66. SIEMENS AG: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 67. SIEMENS AG: REVENUE SHARE BY REGION, 2022 (%)
  • FIGURE 68. QUIDELORTHO CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
  • FIGURE 69. QUIDELORTHO CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)
  • FIGURE 70. QUIDELORTHO CORPORATION.: REVENUE SHARE BY REGION, 2022 (%)